140 related articles for article (PubMed ID: 9619749)
1. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
5. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
Mall JW; Schwenk W; Philipp AW; Meyer-Kipker C; Mall W; Muller J; Pollmann C
Respirology; 2002 Jun; 7(2):99-102. PubMed ID: 11985730
[TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
[TBL] [Abstract][Full Text] [Related]
8. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.
Bremnes RM; Sundstrom S; Aasebø U; Kaasa S; Hatlevoll R; Aamdal S;
Lung Cancer; 2003 Mar; 39(3):303-13. PubMed ID: 12609569
[TBL] [Abstract][Full Text] [Related]
9. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
Hermes A; Gatzemeier U; Waschki B; Reck M
Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.
Tas F; Aydiner A; Demir C; Topuz E
Am J Clin Oncol; 2001 Aug; 24(4):376-8. PubMed ID: 11474266
[TBL] [Abstract][Full Text] [Related]
12. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
Quoix E; Purohit A; Faller-Beau M; Moreau L; Oster JP; Pauli G
Lung Cancer; 2000 Nov; 30(2):127-34. PubMed ID: 11086206
[TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
Buccheri G; Ferrigno D;
Lung Cancer; 2000 Oct; 30(1):37-49. PubMed ID: 11008008
[TBL] [Abstract][Full Text] [Related]
15. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
16. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
[TBL] [Abstract][Full Text] [Related]
17. Peritoneoscopy in the staging of 190 patients with small-cell anaplastic carcinoma of the lung with special reference to subtyping.
Dombernowsky P; Hirsch F; Hansen HH; Hainau B
Cancer; 1978 May; 41(5):2008-12. PubMed ID: 206345
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase values and bone scans as predictors of bone marrow involvement in small-cell lung cancer.
Hamrick RM; Murgo AJ
Arch Intern Med; 1987 Jun; 147(6):1070-1. PubMed ID: 3036032
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
Lassen U; Osterlind K; Hansen M; Dombernowsky P; Bergman B; Hansen HH
J Clin Oncol; 1995 May; 13(5):1215-20. PubMed ID: 7738624
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer.
Chen C; Zhu YH; Huang JA
J Cancer Res Ther; 2018 Jun; 14(Supplement):S336-S340. PubMed ID: 29970686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
